Validation of pharmaceutical potency determinations by quantitative nuclear magnetic resonance spectrometry

Applied Spectroscopy

Volumn 64, Issue 5, 2010, Pages 537-542

  Webster, Gregory K ^a   Marsden, Ian ^a   Pommerening, Cynthia A ^a   Tyrakowski, Christina M ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Active pharmaceutical ingredients; Nuclear magnetic resonance spectroscopy; Q NMR; Quantitative NMR

Indexed keywords

INDUSTRIAL LABORATORIES; LABORATORIES; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; NUCLEAR MAGNETIC RESONANCE; RESONANCE; TOXICITY; TURNAROUND TIME;

ACTIVE PHARMACEUTICAL INGREDIENTS; ANALYTICAL LABORATORIES; DEVELOPMENT TESTING; GOOD MANUFACTURING PRACTICES; LABORATORY PRACTICES; PHARMACEUTICAL ANALYSIS; PHARMACEUTICAL INDUSTRY; QUANTITATIVE NUCLEAR MAGNETIC RESONANCES;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 77952729219     PISSN: 00037028     EISSN: None     Source Type: Journal    
DOI: 10.1366/000370210791211655     Document Type: Article

References (17)

1. J. B. Crowther, W. Lauwers, S. Adusumalli, and P. Shenbagamurthi, "The Laboratory Analyst's Role in the Drug Development Process", in Analytical Chemistry in a GMP Environment, J. M. Miller and J. B. Crowther, Eds. (Wiley, New, York, 2000), Chap. 1, p. 3.
2. F. Kasler, Quantitative Analysis by NMR Spectroscopy (Academic Press, New York, 1973).
3. J. A. Vinson and D. M. Kozak, Am. J. Pharm. Ed. 42, 290 (1978).
4. T. Sako, S. Nakaie, M. Kinoshita, T. Ihara, S. Kinugasa, A. Nomura, and T. Maeda, Metrologia 41, 213 (2004).
5. V. Pinciroli, R. Biancardi, G. Visentin, and V. Rizzo, Org. Proc. Res. Dev. 8, 381 (2004).
6. R. J. Wells, J. Cheung, and J. M. Hook, Accred. Quai. Assur. 9, 450 (2004).
7. U. Holzgrabe, R. Deubner, C. Schollmayer, and B. Waibel, J. Pharm. Biomed. Anal. 38, 806 (2005).
8. V. Rizzo and V. Pinciroli, J. Pharm. Biomed. Anal. 38, 851 (2005).
9. I. C. Jones, G. L. Sharman, and J. Pidgeon, Mag. Reson. Chem. 43, 497 (2005).
10. P. A. Hays, J. Forensic Sci. 50 (6), 1 (2005).
11. G. Shao, R. Kautz, S. Peng, G. Cui, and R. W. Giese, J. Chrom. A 1138, 305 (2007).
12. R. Martino, V. Gilard, F. Desmoulin, and M. Malet-Martino, J. Pharm. Biomed. Anal. 38, 871 (2005).
13. S. K. Branch, J. Pharm. Biomed. Anal. 38, 798 (2005).
14. F. Malz and H. Jancke, J. Pharm. Biomed. Anal. 38, 813 (2005).
15. S. Bekiroglu, O. Myrberg, K. Ostman, M. Ek, T. Arvidsson, T. Rundlof, and B. Hakkarainen, J. Pharm. Biomed. Anal. 47, 958 (2008).
16. R. Sharma, P. K. Gupta, A. Mazumder, D. K. Dubey, K. Ganesan, and R. Vijayaraghavan, J. Pharm. Biomed. Anal. 49, 1092 (2009).
17. G. K. Webster, C. A. Pommerening, I. Marsden, B. Tobias, and C. M. Tyrakowski, J. Pharm. Biomed. Anal. 49, 1261 (2009).